Skip to main content

Table 2 Average daily energy, macronutrient, Vitamin D and mineral intake during r-hPRL or placebo administration

From: Short-term prolactin administration causes expressible galactorrhea but does not affect bone turnover: pilot data for a new lactation agent

  Placebo r-hPRL
  Before treatment After treatment Before treatment After treatment
Energy (kcal) 1963 ± 164 1929 ± 164 1670 ± 190 1606 ± 244
Fat (g) 65. ± 8.4 66.9 ± 6.7 58.3 ± 8.1 55.8 ± 11.4
Protein (g) 67.5 ± 7.5 71.8 ± 7.5 63.8 ± 7.1 62.9 ± 9.9
Carbohydrate (g) 283 ± 23 267 ± 25 225 ± 27 206 ± 33
Vitamin D (μg) 3.7 ± 0.9 4.1 ± 0.9 5.9 ± 3.8 2.9 ± 0.8
Calcium (mg) 849 ± 92 749 ± 113 1019 ± 162 1054 ± 210
Phosphorus (mg) 1166 ± 123 1131 ± 135 1093 ± 106 1029 ± 128
Sodium (mg) 3460 ± 436 3823 ± 497 2505 ± 222 2517 ± 328
  1. All results: mean ± SE